LOS ANGELES | September 19, 2011 - Redwood Capital ("Redwood") has announced the successful completion of a recapitalization of Asylum Research, Inc. ("Asylum" or the "Company") based in Santa Barbara, CA. As part of the recapitalization, Redwood was successful in refinancing a structured note with Asylum held by Agilent Technologies, Inc (NYSE:A). Asylum is the global technology leader in atomic force and scanning probe microscopy (AFM/SPM) for both materials and bioscience applications in the commercial, industrial, and scientific markets. The Company has locations throughout the world including Santa Barbara, CA; Raleigh, NC; Oxford, United Kingdom; Mannheim, Germany; and Kaohsiung, Taiwan.

"Redwood did a terrific job of balancing the complexities of this recapitalization. We are now well positioned to grow our business for the balance of 2011 and into the future" said Jason Cleveland, CEO. "We maintain strong relationships with numerous middle market equity and debt providers, and these contacts along with our ability to understand the complexities of Asylum's business allowed us to provide the Company with an array of different capitalization options and guide them to the solution that was the most beneficial" said Matthew Johnson, Managing Partner.

About Asylum Research, Inc.

Asylum Research, Inc. is the technology leader in atomic force and scanning probe microscopes ("AFM" and "SPM") and related high-precision measurement products. Asylum produces industry-leading quality instruments which it has traditionally sold primarily to academic institutions and government labs, and is now expanding its marketing efforts to opportunistically target more commercial and industrial customers as well. The Company was founded in 1999 and is based in Santa Barbara, CA.